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ABSTRACT 
Anti-bacterial are agents that inhibit bacterial growth or kills bacteria and are a sub-type of antimicrobials. These are drugs used to treat infections, 
but they sometimes pose a threat of adverse events. Some of these adverse events are neuropsychiatric, which are generally hard to diagnose and is 
often paid less attention. They account for about 30% of total Adverse drug reactions (ADRs) caused by drugs in patients without mental 
abnormalities. The spectrum ranges from episodes of seizure to acute psychosis. The article emphasizes the frequency of such adverse events and 
means to raise awareness among medical practitioners regarding the same. The various neuropsychiatric adverse effects and the agents responsible 
have been reviewed, along with their possible mechanisms and general management.  
The information for writing this review was selected by searching for keywords such as Neurotoxicity, GABA, Psychosis, Naranjo scale, and 
Antibiomania in databases such as Google Scholar, PubMed, Elsevier, etc. After searching the articles in the above-mentioned databases, the articles 
were screened concerning their importance with our work and according to their title and abstract. Additional articles were discovered by checking 
the references in the current study's citations. Using this method, the various neuropsychiatric adverse effects of Antibacterial agents were 
summarized in this review. 
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INTRODUCTION 
Antibacterial drugs cover and possess many structural and functional 
characteristics, and the case of one agent may be different from that of 
another [1]. While some of these agents are naturally derived, others 
are synthetic. These agents can be classified based on various features 
such as the mechanism of action, spectrum of the activity 
(bacteriostatic/bactericidal) etc. Here, we would use the structural 
classification of antibacterial agents to explain the neuropsychiatric 
adverse effects caused by them. The classes of importance mentioned 
in context are: Beta-lactams, Fluoroquinolones, Nitrofurans, Amino 
acids, Diaminopyridines, Sulfonamides, Oxazolidinones, Nicotinic acid 
derivatives, Nitroimidazoles, Tetracyclines, Antimycobacterial 
antibiotics, Macrolides, Sulfones, Nitrobenzene derivatives, 
Glycylcyclines, Lipopeptides, and Polypeptide antibiotics [1-6]. 
Antimicrobial-related neurotoxic effects can have a vast array of 
presentations. Patients with focal sensory system illness, renal 
inadequacy and old age might be susceptible to these unwanted effects 
[2]. Conditions such as dizziness, tremors, hallucinations occur in 9-
11% of patients on antibiotics [3]. Any antibiotic can cause an 
increased risk of depression [1]. Other changes in behavioural aspects 
range from insomnia [4] to acute psychosis [5]. Clarithromycin 
induced psychosis, for example, have been reported in 4-30% of 
patients; worst effects are seen on the nervous system in 3% of 
patients which includes dizziness, anxiety, insomnia, bad dreams, 
confusion, disorientation and hallucination [6]. Commonly seen 
neuropsychiatric adverse drug effects upon administration of these 
antibacterials are seizures, psychosis, encephalopathy, peripheral 
neuropathy, optic neuropathy, worsening of myasthenia gravis, 
dizziness/vertigo, headache, and insomnia [1-6], which in detail have 
been discussed inside. Study publications, case reports and review 
articles of relevance with respect to the topic, published during 2004–
2021 were referred to prepare this review.  
Important neuropsychiatric adverse effects reported upon the 
use of anti-bacterial drugs 
Seizures 
Episodes are most commonly associated with antibiotic classes such 
as penicillin, cephalosporins, carbapenem and fluoroquinolones [2, 
4, 7-13]. Other antibiotics associated with seizures include 
Metronidazole, Nitrofurantoin, Cycloserine, Trimethoprim-
sulfamethoxazole (TMP-SMX), Linezolid, Tedizolid and an overdose 
of Isoniazid (INH) [11, 14, 15]. The risk of occurrence is higher with 
Imipenem compared to all other carbapenems [7].  
Though mostly generalized tonic-clonic seizures are seen to be 
associated, cases of simple and complex partial seizures too have 
been reported [2]. An epileptic condition lasting for more than 30 
min is known as Non-convulsive status epilepticus (NCSE), clinically 
manifested by an altered mental state and associated with 
continuous epileptiform activity on the encephalogram [10]. Fourth-
generation cephalosporin and cefepime have been frequently 
reported to cause NSCE. Seizures are mostly subclinical, the only 
clinical feature is a non-localizing encephalopathy, and ultimately 
Electroencephalogram (EEG) is required to make the diagnosis [2]. 
Administration of antimicrobials at doses higher than that 
recommended, age above 50, renal insufficiency, conditions leading to 
alterations of blood-brain barrier such as the presence of a tumor, 
make patients susceptible to seizures [7]. Also, a higher incidence was 
seen when Penicillin or Cephalosporins were in association with 
Antibiotic-Associated Encephalopathy (AAE) [9]. As with 
fluoroquinolones, the risk is increased by concomitant use of Non-
steroidal Anti-inflammatory Drugs (NSAIDs) [11]. Some antibiotics act 
by increasing or decreasing plasma levels of Antiepileptic drugs 
(AEDs) administered to patients. Whereas certain drugs such as Beta-
lactams and Quinolones could possess a proconvulsant activity and 
therefore induce seizures in patients with no history of epilepsy [10]. 
To treat seizures, the culprit drug must be discontinued. 
Management of NCSE involves use of anticonvulsants such as 
Benzodiazepines, Phenytoin and Valproic acid [2, 11].  
Encephalopathy 
Antibiotics such as Metronidazole, Fluoroquinolones, Macrolides, 
Beta-lactams and Sulfonamides are most likely to cause 
encephalopathy [2, 7-11, 16]. The various features of AAE have been 
reviewed by Bhattacharya et al. Based on these features, 
encephalopathy has been categorized into three classes, Type 1, 
Type 2 and Type 3 AAE. Encephalopathy beginning within days of 
antibiotic initiation, with the occurrence of myoclonus or seizures 
International Journal of Pharmacy and Pharmaceutical Sciences 
Print ISSN: 2656-0097 | Online ISSN: 0975-1491                          Vol 13, Issue 12, 2021 
S. T. Cyriac, D. S. Iype 
Int J Pharm Pharm Sci, Vol 13, Issue 12, 1-8 
2 
being common, disturbed EEG, normal Magnetic Resonance Imaging 
(MRI), which resolves within days are referred to as Type 1 AAE. 
Examples of antibiotics associated with Type 1 AAE include penicillin 
and cephalosporins. Characteristics attributed to Type 2 AAE are 
commencement within days of initiation of therapy, psychotic 
episodes which occur frequently, the uncommon occurrence of 
seizures, infrequently abnormal EEG, normal MRI and resolution 
within days. Antibiotics commonly associated with Type 2 AAE are 
Procaine penicillin, Sulfonamides, Fluoroquinolones and Macrolides. 
Type 3 AAE can be attributed to encephalopathy induced by 
Metronidazole alone. The features include onset post a week of drug 
initiation, cerebellar dysfunction occurring frequently, rare seizures, 
rare yet non-specific EEG abnormalities and abnormal MRI [9]. 
EEG monitoring is recommended in patients who are being 
administered with antibiotics of neurotoxic potential. EEG is also 
helpful in distinguishing an episode of NCSE from encephalopathy. 
Once diagnosed, the culprit drug shall be replaced with an agent that 
is not neurotoxic [2]. 
Psychosis 
It is the term used to describe illness in which patients have altered 
perception of reality as evidenced by delusion and/or hallucinations 
[17]. Psychosis, that is delusion and hallucinations were present in 47% 
of cases and were most commonly associated with Sulfonamides (68%), 
Quinolones (67%), Macrolide (63%), and Penicillin IM (68%) 
treatments. In fact, in medical literature, Psychosis is a secondary 
adverse effect caused by Clarithromycin. Psychosis was least seen in the 
case of AAE with Cephalosporins (13%) and Metronidazole (24%) [6, 8].  
The term used to describe an emergency manic episode in a reaction 
to antibiotics is ‘antibiomania’ or Hoigné syndrome [8, 18]. It is a 
rare side effect shown by some antibiotics that resolve after 
cessation of the treatment. Macrolides and quinolones are 
comparatively more commonly associated, and at a lower rate are 
Beta-lactams and Metronidazole [1].  
Several case reports and series provides in detail accounts of 
antibacterial-induced psychosis and their management. The case of 
Imipenem-cilastatin-induced psychosis by Jacob Ninan et al. 
describes an episode of acute psychosis upon an increase of the 
antibiotic dose. The patient experienced intense visual and auditory 
hallucinations due to Imipenem-cilastatin induced psychosis. 
According to the literature, the condition resolves in 2 w of 
discontinuation of the causative agent [13]. 
A case of Metronidazole-induced psychosis has been discussed by 
Mili Khandheria et al. The manifestations (paranoia, delusions, 
auditory hallucinations) shown by the patient met the criteria for 
substance-induced psychosis as under the Diagnostic and Statistical 
Manual of Mental Disorders-IV (DSM-IV). The patient had been 
administering Metronidazole (500 mg twice daily). Psychosis 
resolved 2 d after withdrawal of the drug. The patient was 
prescribed Olanzapine (5 mg twice daily) if her symptoms were to 
recur [3]. Withdrawal of the offending agents and administration of 
Diazepam injection produced an effect in the 28-year old male with 
INH and ethambutol induced psychosis, reported by Prasad R et al. 
[17]. We also see Risperidone being used to treat hallucinations 
caused by Trimethoprim-sulfamethoxazole which was prescribed 
for Urinary tract infection (UTI). The antibiotic, therefore, was 
substituted with Nitrofurantoin in this case report by Matej Stuhec 
[19]. Surprisingly, unlike these cases, Minocycline has been reported 
to produce improvements in patients with psychotic disorders. The 
drug has anti-inflammatory properties and is said to be capable of 
producing an effect on neurotransmitters as well as their receptors 
[20]. But it was also seen listed among antibiotics causing psychosis, 
and therefore cannot be ruled out completely off the picture [13].  
An example of psychosis associated with type2 AEE is Procaine 
penicillin (9). The cases show a relationship between psychosis and 
the administered antibiotic. However, in some cases, the underlying 
infectious condition itself (and not the antimicrobial) may be 
associated with exacerbation of psychosis. For example, the 
prevalence of comorbid infections during episodes of psychosis 
among schizophrenic patients, especially UTI are high [21]. A similar 
observation is the association between UTI and acute psychosis seen 
among geriatric patients [22]. Another relationship between 
infection and psychosis is marked by the increased risk of psychosis 
in an offspring whose mother experienced Genito-urinary infections 
or maternal fever during pregnancy [16]. 
  
Table 1: Drugs causing seizure, psychosis and encephalopathy 
Condition Class of drugs Drugs References 
Seizure Beta-lactams Penicillin, Piperacillin, Cefepime, Cefixime, Cefazolin, 
Cefuroxime, Ceftazidime, Imipenem, Meropenem 
[2, 7-11, 13] 
Fluroquinolones Ciprofloxacin, Levofloxacin, Ofloxacin, Moxifloxacin, 
Gatifloxacin, Norfloxacin 
[2, 4, 7, 11, 12] 
Nitrofurans Nitrofurantoin [14] 
Amino acid Cycloserine [15] 
Diaminopyridine-Sulfonamides Trimethoprim-Sulfamethoxazole  [11] 
Oxazolidinones Linezolid, tedizolid 
Nicotinic acid derivatives Isoniazid (on overdose) 
Nitroimidazoles Metronidazole 
Psychosis Beta-lactams Penicillin, Procaine Penicillin, Procaine benzyl penicillin, 
Piperacillin, Amoxicillin, Cefalexin, Meropenem, Imipenem 
[1, 8, 9, 11, 13, 16, 21, 22] 
Fluroquinolones Ciprofloxacin, Ofloxacin, Norfloxacin, Temafloxacin, 
Gatifloxacin, Levofloxacin, Moxifloxacin 
[1, 2, 4, 8, 9, 11-13, 16, 21-25] 
Macrolides Clarithromycin, Clindamycin, Erythromycin [1, 6, 8, 9, 11, 13, 16, 21] 
Tetracyclines Tetracycline, Doxycycline, Minocycline [13, 21] 
Aminoglycosides Amikacin, Gentamicin,  
Nitroimidazoles Metronidazole [1, 3, 8, 9, 11, 13, 21] 
Diaminopyridine-Sulfonamide Trimethoprim-Sulfamethoxazole [1, 2, 8, 9, 11, 13, 16, 19, 22, 26] 
Nicotinic acid derivative Isoniazid [11, 13, 17] 
Antimycobacterial antibiotics Ethambutol [17] 
Amino acid Cycloserine [3] 
Encephalopathy Beta-lactams Penicillin, Benzyl penicillin, Piperacillin, Procaine 
penicillin, Cefepime, Ceftazidime, Cefazolin, Cefuroxime 
[2, 7, 9-11, 16] 
Fluoroquinolones Gemifloxacin [2, 7, 9, 11, 16] 
Macrolides Clarithromycin [7, 9, 11, 16] 
Nitroimidazole Metronidazole [2, 7-9, 11] 
Diaminopyridine-Sulfonamide Trimethoprim-Sulfamethoxazole,  [2, 7, 9, 11, 16] 
Nicotinic acid derivative Isoniazid (overdose) [11] 
Oxazolidinones Linezolid [2, 11] 
Aminoglycosides Gentamicin 
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Peripheral neuropathy 
Drug-induced peripheral neuropathy takes place when damage to 
the nervous system has been caused by a chemical substance. It 
could be irreversible and may lead to paresthesia. Awareness 
among healthcare practitioners is important, especially when 
patients undergoing treatment with these drugs complain of pain, 
numbness, weakness, paresthesia or autonomic dysfunction. The 
duration required for the onset of these symptoms ranges from 
weeks to months [7, 27]. The various types of peripheral 
neuropathy are classified based on symptoms present – Sensory, 
motor, sensorimotor, and autonomic. It can also be classified 
based on pathophysiology or according to the type of nerve fibre 
affected. Once diagnosed, management requires discontinuation of 
the offensive agent and in the case of INH-induced peripheral 
neuropathy, Pyridoxine supplementation [11]. 
It is induced mainly by antibiotic drugs such as Fluoroquinolones, 
Metronidazole, Linezolid and INH [2, 3, 7, 11, 17, 24]. With INH, the 
most observed adverse effect concerning the neuropsychological 
context is peripheral neuropathy itself [11, 17]. The onset of INH-
induced peripheral neuropathy varies and may take up to 6 mo. higher 
doses of INH have been found to increase the risk of developing 
peripheral neuropathy. Concomitant intake of Pyridoxine is therefore 
advised [27]. Disease conditions that cause peripheral neuropathy, old 
age, malnutrition, and pregnancy are risk factors too [11]. 
As with Fluoroquinolones, in 2013 the Food and Drug 
Administration (FDA) wanted the label of Fluoroquinolones 
changed to highlight the risk of peripheral neuropathy [28, 11]. 
Later in 2014, in a study of 6,226 cases and 24,904 controls, 
conducted by Mahyar Etminan et al., the risk of peripheral 
neuropathy with oral Fluoroquinolones were analyzed. The results 
revealed a risk ratio of 1.83 among current users and 2.07 among 
current new users [28]. 
The incidence is as high as 50% with Metronidazole and Linezolid, 
when these drugs are used for a long duration, or when 
Metronidazole is used concomitantly with Selective serotonin 
reuptake inhibitors (SSRIs) [7, 2]. Metronidazole-induced peripheral 
neuropathy may be present alone or in association with 
Metronidazole induced encephalopathy (MIE). Linezolid-induced 
optic neuropathy is often preceded by peripheral neuropathy, which 
may continue despite the withdrawal of the offending agent and 
resolution of symptoms of the eye [2, 11]. 
Polymyxin, Telavancin, Daptomycin, Linezolid and Nitrofurantoin 
are the agents that account for paresthesia. It is recommended that 
Linezolid shall be administered only for a maximum duration of 28 d 
as it may cause paresthesia of extremities of the body. 
Nitrofurantoin-related peripheral neuropathy is said to begin as 
paresthesia of distal extremities, which later develops dysesthesia. 
Other antibiotics capable of causing peripheral neuropathy are 
Dapsone, Chloramphenicol, Gentamicin, Ethambutol, and 
Sulfasalazine [2, 7, 11], as shown in table 2.  
Optic neuropathy 
Antibiotics have also been found to cause optic neuropathy. The 
causative agents include many antibiotics such as Ethambutol, 
Linezolid, Ciprofloxacin, Levofloxacin, Chloramphenicol, 
Metronidazole, INH, Streptomycin and Sulfonamides. Ethambutol 
and Linezolid were the most commonly reported agents. 
Manifestations associated with optic neuropathy include painless, 
progressive loss of vision of both eyes. There could be a reduction in 
colour vision, i.e., the patient may fail to discriminate between red 
and green. Optic neuropathy induced by antibiotics is often 
reversible, which means the patient returns to normal once the drug 
is withheld [2, 7, 11]. 
Linezolid-induced optic neuropathy can be identified by some 
additional features, such as optic disc swelling or pallor, loss of 
central vision (more than that of peripheral vision). It is reversible in 
nature. When compared to Linezolid, a better alternative would be 
Tedizolid since it shows a much lower risk towards the development 
of optic neuropathy [11]. 
Risk factors associated with Ethambutol-induced optic neuropathy 
are prolonged therapy, higher doses, old age (above 60 y), 
hypertension and renal dysfunction. The onset of the condition may 
vary from 1-9 mo. The nature of Ethambutol-induced optic 
neuropathy may be irreversible at times. It can cause permanent 
loss of vision, though it is unlikely to occur in most patients. In cases 
where it is reversible, improvement is seen within 3 mo. [11] 
 
Table 2: Drugs causing peripheral neuropathy, optic neuropathy and exacerbation of myasthenia gravis 
 Condition Class of drugs Drugs References 
Peripheral 
Neuropathy 
Oxazolidinone Linezolid [2, 7, 11, 27] 
Sulfones Dapsone [7] 
Nitrobenzene derivatives Chloramphenicol 
Sulfonamides Sulfasalazine 
Aminoglycosides Gentamicin,  [2, 11] 
Fluroquinolones Ciprofloxacin, Levofloxacin, Moxifloxacin [7, 11, 24, 28] 
Lipopeptides Daptomycin [11] 
Lipoglycopeptide Telavancin 
Nicotinic acid derivative Isoniazid [7, 11, 17, 27] 
Nitrofurans Nitrofurantoin [7, 11] 
Nitroimidazoles Metronidazole [27] 
Antimycobacterial antibiotics Ethambutol [7, 11, 27] 
Optic neuropathy Oxazolidinones Linezolid [2, 7, 11] 
Fluoroquinolones Ciprofloxacin, Levofloxacin [7] 
 Nitrobenzene derivatives Chloramphenicol 
Sulfonamides - 
Aminoglycosides Streptomycin 
Nitroimidazoles Metronidazole [2, 7] 
Nicotinic acid derivatives Isoniazid [7, 11] 
Exacerbation of 
Myasthenia gravis 




Polypeptide antibiotics Colistin, Polymyxin-B [2, 7] 
Beta-lactam Ampicillin, Ceftolozane, Ceftaroline, 
Doripenem, Imipenem 
[2, 7, 11] 
‘-‘indicates that a specific agent was not mentioned among the given references. 
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Exacerbation of myasthenia gravis 
This event has been reported with the use of Polymyxins such as 
Colistin and Polymyxin B. Other than this, Aminoglycosides, 
Fluoroquinolones, Macrolides, Tetracyclines, Ampicillin, and 
Imipenem are the antibiotics implicated [2, 7, 11]. Myasthenia gravis 
is an autoimmune disorder. Clinical manifestations of Myasthenia 
gravis are diplopia, ptosis, dysarthria, dysphagia, proximal limb 
weakness. These symptoms are worsened by activity or towards the 
end of the day. The exacerbation of this condition could be of 
seriousness, stretching between mild to severe. When severe, the 
patient may suffer from respiratory failure and therefore require 
ventilatory support, as denoted by the term ‘myasthenic crises’. 
Polymyxin injections may lead to a respiratory failure lasting 10-48 
h. Close monitoring of symptoms is recommended in patients with 
myasthenia gravis, taking antibiotic medications [2, 7, 12]. 
Headache 
Fluoroquinolones, Beta-lactams, Oxazolidinones, Sulfonamides, 
Lipoglycopeptides, Clarithromycin, Polymyxins, Tigecycline, 
Minocycline, Daptomycin, Nitrofurantoin, INH, Rifampicin, 
Metronidazole and Dalfopristin-quinupristin, have been reported to 
cause headache [2, 4, 11, 12, 23, 24, 29]. 
It is a common side effect seen with Sulfonamides [11]. Among 
Beta-lactams, headache is said to be common with the use of 
Doripenem and Ceftaroline [2]. A mild headache could be 
accompanied by Rifampin administration. Among Oxazolidinones, 
Linezolid and Tedizolid had headache listed among their most 
common side effects during the ESTABLISH trial [11]. Clinical 
trials with Dalbavancin shows that the major neurological side 
effect associated with the drug is headache, which was 
experienced by 25% of the subjects [30]. Dalbavancin, as well as 
Telavancin (another Lipoglycopeptide), are drugs of importance in 
cases of complicated skin and skin structure infections where 
Vancomycin fails to produce effect [31]. The safety of Telavancin 
was assessed in a randomized comparative study conducted by 
Michael W. Dunne et al. A total of 1778 patients were enrolled. A 
dose of 500 mg was administered on the first day and 1000 mg on 
the 8th day for treatment of skin and skin structure infections. The 
results of the study mention headache as one of the important side 
effects associated with this drug [32].  
Apart from these, Streptogramins are agents whose usage has been 
limited to the treatment of infections caused by Vancomycin-
resistant enterococci (VRE). Headache is the only neuropsychiatric 
adverse event seen with their use [2]. 
Dizziness/vertigo 
Dizziness and vertigo are conditions that occur as a result of vestibular 
toxicity [11]. In the case review by Serafina Chimirri et al., Dizziness 
has been defined as a general term used to express subjective 
complaints of the patient in connection with the changes in sensation, 
movement, perception or consciousness. Vertigo, however, is a 
subtype of dizziness and has been defined as an illusion of movement 
caused by asymmetric involvement of the vestibular system [33]. As 
mentioned in table 3, Fluoroquinolones, Polymyxins, Clarithromycin, 
Metronidazole, Minocycline, Tigecycline, Daptomycin, Gentamicin, 
Vancomycin, Linezolid, Nitrofurantoin, Rifampin and Ethambutol [2, 4, 
6, 11, 12, 17, 23, 24, 29, 33] are the agents found to be associated with 
Dizziness/Vertigo.  
The case report by Boonsong Kiangkitiwan et al. briefs an incident of 
levofloxacin-induced delirium with psychotic features where the 42-
year old female patient experienced neuropsychiatric adverse 
effects, including dizziness [4].  
  
Table 3: Drugs causing headache, dizziness/vertigo and insomnia 
 Condition Class of drugs Drugs References 
Headache Macrolides Clarithromycin [11, 29] 
Fluoroquinolones Ofloxacin, Gemifloxacin, Ciprofloxacin, Moxifloxacin [2, 4, 11, 12, 23, 24] 
Polypeptide antibiotics Polymyxin [11] 
Glycylcyclines Tigecycline 





Nicotinic acid derivatives Isoniazid 
Antimycobacterial antibiotics Rifampin 
Nitroimidazoles Metronidazole [2] 
Streptogramins Dalfopristin-quinupristin 
Lipoglycopeptides Dalbavancin, Telavancin, Oritavancin [11, 30-32] 
Beta-lactams Ceftolozane, Ceftaroline [11, 34] 
Dizziness/vertigo Fluoroquinolones Ciprofloxacin, Ofloxacin, Moxifloxacin, Gemifloxacin, 
Levofloxacin 
[2, 4, 11, 12, 23, 24, 33] 
Nitroimidazoles Metronidazole [2] 
Macrolides Clarithromycin [6, 29] 
Polypeptide antibiotics Polymyxin  [2, 11] 







Antimycobacterial antibiotics Rifampin, Ethambutol [11, 17] 
Beta-lactams Amoxicillin-clavulanic acid [33] 
Insomnia Glycylcyclines Tigecycline [11] 
Lipopeptides Daptomycin 
Oxazolidinones Linezolid 
Nicotinic acid derivatives Isoniazid 
Polypeptide antibiotics Polymyxin B 
Fluoroquinolones Levofloxacin, Moxifloxacin [2, 11, 24] 
Lipoglycopeptides Dalbavancin, Telavancin [11, 32] 
Beta-lactams Ceftolozane [11, 34] 
Macrolides Azithromycin, Clarithromycin [6, 29] 
‘-‘indicates that a specific agent was not mentioned among the given references. 
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Insomnia 
It refers to the difficulty initiating or maintaining sleep, or both. 
Antibiotics causing insomnia are Fluoroquinolones, Cephalosporins, 
Macrolides, Tigecycline, Dalbavancin, Telavancin, Daptomycin, 
Linezolid, INH [2, 4, 6, 11, 12, 23, 29, 32]. 
In a case series consisting of 3 individual cases published by Arun 
Kandasamy et al., we see patients with lower respiratory tract infections 
who underwent Levofloxacin therapy. The patients experienced 
insomnia which was caused by Levofloxacin itself. The first case is that of 
a 30-year old male patient who took levofloxacin 500 mg for 5 d on a 
once-daily basis. Another case is that of a 30-year old female patient who 
took Levofloxacin 500 mg daily. The last case is that of a patient who self-
medicated himself with a 750 mg dose of Levofloxacin. All three patients 
had their symptoms of anxiety and insomnia resolved once Levofloxacin 
was stopped. None of the patients took drugs other than Levofloxacin, 
nor did any show history of psychiatric illness. Thus, Levofloxacin was 
the offending agent here [12]. 
Mechanisms involved in the causation of neuropsychiatric 
adverse effects by various anti-bacterial agents:  
For antibiotics associated with psychotic abnormalities such as 
Fluoroquinolones, Cephalosporins, Penicillins, and Trimethoprim-
sulfamethoxazole drugs, several possible mechanisms have been 
proposed. There is proof as assessed, that anti-infectives can cause 
intense responses such as seizures. The drugs reaching harmful amounts 
in the bloodstream, their anti-inflammatory properties and their ability 
to inhibit prostaglandin E-2, or cause Gamma-aminobutyric acid (GABA) 
antagonism, and N-methyl-D-aspartate (NMDA) receptor hypo 
functioning are a few of the possible mechanisms. The last two factors 
have generally been discussed as mechanisms that serve as the basis for 
Schizophrenic disorder [8]. Investigations are suggesting that Quinolones 
such as Levofloxacin cause acute anxiety and insomnia by antagonism of 
the inhibitory GABA and direct activation of excitatory NMDA receptors. 
The structural similarity between Fluoroquinolones and GABA could be 
held reason for their antagonistic activity. They also act directly on Alpha-
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors. 
These mechanisms are connected to the non-dopaminergic pathways for 
the development of psychosis [12, 21, 24]. In addition to these, the 
moderately lipophilic nature of Fluoroquinolones increases their ability to 
cross the blood-brain barrier [21]. The effect produced by Benzodiazepines 
and Barbiturates are effective treatment strategies in cases of 
Cephalosporin-induced epileptiform activity that supports the possibility of 
GABA blockade by Cephalosporins to cause neurotoxicity [10].  
GABA class A receptor (GABAAR) of stellate cells of the cerebellar region 
is controlled by the level of mitochondrial reactive oxygen species 
(mROS) at inhibitory synapses. Some antibiotics which are likely to 
target pathogens will also bind with mitochondria of brain cells, for 
example, Minocycline causing antimicrobial-induced mania. Changes in 
behaviour could be attributed to the use of drugs such as Ciprofloxacin, 
Metronidazole, Ofloxacin, TMP-SMX, Cotrimoxazole, Procaine penicillin 
and Clarithromycin, as GABA receptor binding could be inhibited by 
these drugs [25]. The pathway involving Levofloxacin-incited delirium 
stays to be explained. It is conceivable that Quinolone-related NCSE is 
responsible,  as Quinolones are known to bring down the seizure edge by 
competitively binding to the GABAAR [4]. Macrolides and Quinolones are 
the classes commonly prone to antibiomania. The mechanism 
underlying this condition is hypothesized to be caused by GABA 
antagonism, antibiotic-induced mitochondrial dysfunction, Cytochrome 
P450 3A4 (CYP3A4) inhibitory effect or abnormalities with the 
microbiota. In any case, the use of antibiotics is most certainly associated 
with infectious and immune-related disorders [1, 21]. 
The mechanism involved in Type1 AAE is the inhibition of ligand-gated 
ion channel, which is also linked with GABAAR. Type 2 is thought to be 
associated with Dopamine abnormalities and the NMDA pathway. The 
last type, type 3 might be due to free radical formation and alterations 
which may occur in Thiamine metabolism [8].  
The Tetracycline drugs, such as Minocycline and Doxycycline, have 
immunoregulatory as well as anti-inflammatory properties. They 
also possess good Central nervous System-penetration 
characteristics. These drugs have been found to produce anti-
inflammatory effects in in vivo and in vitro conditions, both. They 
may therefore act on neurons and glia [1]. The ability of the drug to 
penetrate and reach toxic levels has been inflicted in TMP-SMX 
related hallucinations as well [19]. Impairment in metabolism and 
reduced clearance of the drug adds to the challenge [26]. 
INH causes increased excretion of Pyridoxine, resulting in this vitamin’s 
deficiency. As a result, the usual Tryptophan metabolism gets disturbed. 
Brain pyridoxal-5-phosphate too is inhibited by this antibiotic since this 
coenzyme is produced from pyridoxine itself. Inhibition of the enzyme 
results in a decrease in GABA of the brain and other synaptic 
transmitters. Thus neurological adverse effects are elicited. Conditions 
such as diabetes mellitus, hepatic insufficiency, old age, alcoholism, and 
family and personal history of mental illness predisposes the patient 
towards INH-induced neuropsychiatric adverse effects [17, 27].  
Another mechanism suggested to comply with the case report 
published by Mili Khandheria et al., is that the enzyme, monoamine 
oxidase (MAO) is reversibly inhibited by Metronidazole. The enzyme 
involved in the Dopamine pathway is responsible for its breakdown. 
Thus a decrease in MAO results in excess Dopamine. Since the 
inhibition is reversible, this explanation backs the fact that the 
patient recovered after Metronidazole was stopped [3]. Another 
possible explanation for Metronidazole-induced neurotoxicity, 
which involves cytotoxic and vasogenic oedema was also put 
forward [21]. 
Evaluation and management 
Diagnostic criteria for psychiatric disorders are mentioned in DSM-
IV [17]. The Diagnostic and Statistical Manual of Mental Disorders–V 
(DSM-V) was used to confirm psychosis induced by Imipenem-
cilastatin in the case report by Jacob Ninan et al. [13]. Naranjo 
adverse drug reaction probability scale (table 4) has helped in the 
assurance of ADRs in many cases referred; A score over 9 
demonstrates definite ADR while 5-8 means a probable ADR. Scores 
1-4 insights possible ADR, and zero a doubtful ADR [9, 13, 19, 24, 29]. 
EEG and MRI could be of use in cases of AAE and seizures [2, 9]. A 
strategy commonly used to confirm substance-induced psychosis is 
by ensuring the resolution of symptoms with the withdrawal of the 
drug and their recurrence on rechallenge with the same agent [2, 11, 
13, 22, 35,36]. However, performing a rechallenge may not be 
justifiable at all times [29]. Challenges to the diagnosis of 
Fluoroquinolone-related neurotoxicity include False-positive urine-
opiate immunoassay reports caused by their ability to cross-react 
with the Enzyme immunoassay (EIA) screens for opiate drugs [4]. 
 
Table 4: Naranjo adverse drug reaction probability scale 
Question Yes No Do not 
know 
Score 
1. Are there previous conclusive reports on this reaction?  +1 0 0  
2. Did the adverse event appear after the suspected drug was administered?  +2 -1 0  
3. Did the adverse reaction improve when the drug was discontinued or a specific antagonist was administered?  +1 0 0  
4. Did the adverse reaction reappear when the drug was re-administered?  +2 -1 0  
5. Are there alternative causes (other than the drug) that could on their own have caused the reaction?  -1 +2 0  
6. Did the reaction reappear when a placebo was given?  -1 +1 0  
7. Was the drug detected in blood (or other fluids) in concentrations known to be toxic?  +1 0 0  
8. Was the reaction more severe when the dose was increased or less severe when the dose was decreased?  +1 0 0  
9. Did the patient have a similar reaction to the same or similar drugs in any previous exposure?  +1 0 0  
10. Was the adverse event confirmed by any objective evidence?  +1 0 0  
 Total Score  
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Naranjo ADR Probability Scale: A method for estimating the 
probability of adverse drug reactions. Clin Pharmacol Ther. 1981 [37]. 
A close association is often seen between the administration of 
antibiotics and the occurrence of adverse events. Once the condition 
is diagnosed, the primary step in management would be to withdraw 
the causative agent and substitute it with a non-neurotoxic 
antibiotic. In many a case, this leads to the cessation of the adverse 
effect. In contrast to this, rare cases like that of Nitrofurantoin-
induced dysesthesias may cause irreversible damage. This infers 
that the withdrawal of the drug does not undo the harm caused. 
With some antibiotics, however, adverse effects are caused in a 
dose-dependent fashion, in such cases, dosage adjustments are 
necessitated [2, 38-51]. It may not be practical to completely 
withdraw the causative agent at all times though [39].  
Treatment of the condition may be performed alongside if necessary. 
A case of secondary mania may be treated with antipsychotics, 
benzodiazepines and mood stabilizers. The use of second-generation 
antipsychotics is considered better in comparison with the first-
generation. The initial steps to manage seizure would be stabilization 
of the airways, maintenance of blood pressure and pulse, 
measurement of serum glucose levels and management of 
hyperthermia. In the case of NCSE, anticonvulsants may be required 
for treatment. Other forms of epilepsy or tremors shall be treated with 
Anti-epileptic drugs. Myasthenic syndrome caused by polymyxin may 
have to be aided with ventilatory support. It is decided based on the 
degree of respiratory impairment [2, 39, 52-60].  
If the renal function is impaired and diagnosis of antibiotic-induced 
neurotoxicity is confirmed, haemodialysis or hemofiltration may 
have to be performed to ensure adequate clearance of the drug. A 
high-volume continuous venovenous hemofiltration (CVVHF) can be 
used to optimize drug clearance. Drugs with a low tendency towards 
protein binding can easily be controlled by CVVHF. Medication doses 
should be cautiously adjusted in patients with renal dysfunction [2]. 
Conditions such as higher prevalences of nosocomial infections and 
cases of antimicrobial resistance in Intensive care unit-like settings 
complicates the threat further [61]. 
CONCLUSION 
We would recommend the usage of antibiotics to be performed 
strictly, as per protocols. Since neurotoxic impacts of antimicrobials 
are hard to perceive, their occurrence is regularly disparaged. It 
turns out to be significantly difficult in patients with meningitis-like 
neurological ailments. Lasting side effects may lead to further 
complications. Given the globally wide utilization of antimicrobial 
agents like Amoxicillin, for example, neuropsychiatric complications 
can't be overlaid. Consequently, there is a requirement for expanded 
watchfulness during treatment with such medicines. Regular 
monitoring should be warranted whenever culprit drugs are employed 
in the treatment, particularly when higher doses are used. Awareness 
about antibiotics associated with neurotoxic side effects may improve 
overall healthcare. The maintenance of a proper database could help in 
the identification of the population at risk, quicker diagnosis and 
treatment. Of equal importance is Hospital based-intensive 
monitoring, which has proved to be a great way of detecting 
relationships between drug exposure and consequent adverse drug 
reactions. Diligent vigilance is required to find out potential neurotoxic 
effects and to provide patients with optimum therapy. ADRs reduce 
the quality of life and therefore, treatment should always aim at 
improving it. Strong vigilance and the data implicated helps in 
increasing the knowledge of health professionals in these areas. 
Pharmacists should therefore participate in clinical rounds and 
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